Personalized Medicine. 2014;11(7):669-679. In this article, we will describe the current status of personalized medicine for chronic, complex diseases using chronic obstructive pulmonary disease ...

Research and Development costs for targeted oncology drugs are markedly lower if guided by a companion diagnostic strategy, but current biopharmaceutical business models suggest these savings will not ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

The global Personalized Medicine Market is valued at USD 550.2 Billion in 2024 and is projected to reach a value of USD 1302.7 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 8.15% between ...

Personalized medicine offers the hope of more precise diagnostic classification, leading to more successful targeted therapeutics. There have been a number of success stories in personalized ...

A recent study could help repurpose existing drugs, develop new medicines targeted to broad disease processes, and eventually ...

New analysis from Frost & Sullivan, reveals that the predictive medicine, pharmacogenomic, and prenatal and newborn screening will experience significant growth over the next decades. with the ...

On the other hand, concierge medicine promises to allow: • Immediate access and convenience. • Personalized, preventive care. • Physician satisfaction and work-life balance. • Technology ...

One such innovation—concierge medicine—has grown rapidly in popularity. By offering patients enhanced access and personalized care for a membership fee, concierge programs deliver benefits ...

This is where personalized medicine comes into play — a new direction in healthcare that combines biotechnology, big data analytics and consideration of individual patient needs to offer more tailored ...

Moreover, the panelists emphasized that real-world evidence goes beyond clinical trial data. It involves continuous patient ...